Lexaria Bioscience Corp. LEXX 40.85
Health Care · NASDAQ · Data as of 2026-10-02
Lexaria Bioscience Corp. (LEXX) has delivered +25.4% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1386 of 1968 stocks overall and #171 of 260 in the Health Care sector by Steady Score.
Industry
Pharmaceutical Preparations
Steady Score
40.85
Overall Rank
#1386 / 1968
Sector Rank
#171 / 260
Revenue CAGR
+25.4%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio